🇺🇸 FDA
Patent

US 10639383

Methods and compositions for engineering immunity

granted A61KA61K2039/505A61K35/12

Quick answer

US patent 10639383 (Methods and compositions for engineering immunity) held by Sangamo Therapeutics, Inc. expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K35/12, A61K35/28, A61K48/0058